Does mean platelet volume/lymphocyte count ratio associate with frailty in type 2 diabetes mellitus? | Zendy

Satılmış Bilgin | Zendy; Gülali Aktaş | Zendy; Gizem Kahveci | Zendy; Burçin Meryem Atak Tel | Zendy; Özge Kurtkulağı | Zendy; Tuba Taslamacıoğlu Duman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does mean platelet volume/lymphocyte count ratio associate with frailty in type 2 diabetes mellitus?

Author(s) -

Satılmış Bilgin,

Gülali Aktaş,

Gizem Kahveci,

Burçin Meryem Atak Tel,

Özge Kurtkulağı,

Tuba Taslamacıoğlu Duman

Publication year - 2021

Publication title -

bratislavské lekárske listy/bratislava medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.387

H-Index - 32

eISSN - 1336-0345

pISSN - 0006-9248

DOI - 10.4149/bll_2021_017

Subject(s) - mean platelet volume , type 2 diabetes mellitus , diabetes mellitus , medicine , platelet , lymphocyte , immunology , endocrinology

Frailty is a common problem in patients with type 2 diabetes mellitus (T2DM). It is considered to be associated with inflammation. Novel markers derived from hemogram, such as neutrophil/lymphocyte ratio (NLR) and mean platelet volume/lymphocyte ratio (MPVLR), are proposed as inflammatory markers. In present study, we aimed to compare NLR and MPVLR levels of frail patients with T2DM to non‑frail diabetic subjects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research